High expression of PTEN was able to promote protein kinase B (PKB/AKT) activity while inhibit hexokinase 1 (HK1) ubiquitination, thereby stimulating tumorigenesis of chronic myelocytic leukemia (CML) cells [62]. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.